Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RVNC | ENGN | QURE | ||
Company | Revance Therapeutics | Engene Holdings Inc | Uniqure N.V. | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 3.69 | 8.99 | 7.72 | ||
High | 3.75 | 9.27 | 7.81 | ||
Low | 3.61 | 8.85 | 7.56 | ||
Last | 3.64 | 8.85 | 7.51 | ||
Change | +0.01 | -0.14 | -0.23 | ||
% Change | +0.28% | -1.56% | -2.97% | ||
Volume | 72,757 | 9,327 | 131,251 | ||
20-Day Average Volume | 1,906,480 | 137,854 | 7,474,623 | ||
Previous Close | 3.64 | 8.99 | 7.74 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.06 | 8.89 | 6.34 | ||
20-Day Raw Stochastic | 64.97% | 57.65% | 52.49% | ||
20-Day Relative Strength | 57.31% | 41.78% | 60.18% | ||
Weighted Alpha | -76.93 | -49.58 | -55.61 | ||
Today's Opinion | 40% Sell | N/A | 56% Buy | ||
Previous Opinion | 56% Sell | N/A | 56% Buy | ||
Last Month's Opinion | 88% Sell | N/A | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -4.20% since 07/15/24 | -1.11% since 07/15/24 | -15.15% since 07/15/24 | ||
Low | 3.56 on 07/18/24 | 8.66 on 07/16/24 | 7.59 on 07/19/24 | ||
High | 4.38 on 07/17/24 | 9.40 on 07/16/24 | 10.02 on 07/17/24 | ||
1-Month | |||||
%Chg | +37.22% since 06/21/24 | -1.11% since 06/21/24 | +68.41% since 06/21/24 | ||
Low | 2.30 on 06/26/24 | 7.61 on 06/25/24 | 3.73 on 07/05/24 | ||
High | 4.38 on 07/17/24 | 9.85 on 07/08/24 | 11.35 on 07/10/24 | ||
3-Month | |||||
%Chg | +0.27% since 04/22/24 | -39.86% since 04/22/24 | +60.37% since 04/22/24 | ||
Low | 2.30 on 06/26/24 | 6.91 on 06/05/24 | 3.73 on 07/05/24 | ||
High | 4.47 on 05/09/24 | 16.62 on 04/29/24 | 11.35 on 07/10/24 | ||
6-Month | |||||
%Chg | -39.47% since 01/22/24 | +18.67% since 01/22/24 | +35.61% since 01/22/24 | ||
Low | 2.30 on 06/26/24 | 6.91 on 06/05/24 | 3.73 on 07/05/24 | ||
High | 7.56 on 03/01/24 | 18.40 on 03/26/24 | 11.35 on 07/10/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 379,672 | 397,052 | 375,769 | ||
Shares Outstanding, K | 104,449 | 44,166 | 48,549 | ||
Annual Sales | 234,040,000 | 0 | 15,840,000 | ||
Annual Net Income | -323,990,000 | 30,000 | -308,480,000 | ||
Last Quarter Sales | 51,940,000 | 0 | 8,490,000 | ||
Last Quarter Net Income | -53,150,000 | -14,980,000 | -65,620,000 | ||
60-Month Beta | 0.98 | -0.63 | 0.97 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.54 on 05/09/24 | -0.38 on 06/14/24 | -1.36 on 05/07/24 | ||
Latest Earnings Date | 08/13/24 | N/A | 08/06/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | 12/24/14 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |